3.39
price down icon2.59%   -0.09
after-market Handel nachbörslich: 3.49 0.10 +2.95%
loading

Genelux Corp Aktie (GNLX) Neueste Nachrichten

pulisher
Jan 06, 2026

Multiple Insiders Sold Genelux Shares Presenting Weak Signs For Investors - simplywall.st

Jan 06, 2026
pulisher
Jan 05, 2026

After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - Nasdaq

Jan 05, 2026
pulisher
Jan 05, 2026

Genelux data update indicates disease early control, says H.C. Wainwright - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Genelux reports encouraging interim data for Olvi-Vec trials - MSN

Jan 05, 2026
pulisher
Jan 05, 2026

Maintaining Buy on Genelux: Early Olvi-Vec Data Signal Differentiated Potential in Relapsed/Refractory Lung Cancer - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Genelux stock maintains Buy rating at H.C. Wainwright on promising cancer trial data - Investing.com India

Jan 05, 2026
pulisher
Jan 05, 2026

Genelux reports interim data of systemic administration of Olvi-Vec - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Genelux Reports Encouraging Interim Data for Olvi-Vec Trials - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Experimental treatment shrank lung tumors up to 85% in early trial - Stock Titan

Jan 05, 2026
pulisher
Jan 03, 2026

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - Sahm

Jan 03, 2026
pulisher
Jan 03, 2026

Genelux (NASDAQ:GNLX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Jan 03, 2026
pulisher
Jan 03, 2026

Genelux appoints Jason Litten as chief medical officer By Investing.com - Investing.com Nigeria

Jan 03, 2026
pulisher
Jan 02, 2026

Genelux Appoints Veteran Oncologist Jason Litten as CMO - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

Genelux appoints Jason Litten as CMO - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

Genelux Corporation Announces Appointment of Jason Litten as Chief Medical Officer, Effective January 2, 2026 - marketscreener.com

Jan 02, 2026
pulisher
Jan 02, 2026

Genelux appoints Jason Litten as chief medical officer - Investing.com India

Jan 02, 2026
pulisher
Jan 02, 2026

Genelux Corporation Appoints Dr. Jason Litten as Chief Medical Officer to Advance Olvi-Vec Development - Quiver Quantitative

Jan 02, 2026
pulisher
Jan 02, 2026

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewswire Inc.

Jan 02, 2026
pulisher
Jan 01, 2026

Genelux stock maintains Buy rating at H.C. Wainwright on promising cancer trial data By Investing.com - Investing.com Nigeria

Jan 01, 2026
pulisher
Dec 28, 2025

GENELUX CORP : BENCHMARK CUTS TARGET PRICE TO $23 FROM $25 - 富途牛牛

Dec 28, 2025
pulisher
Dec 23, 2025

How interest rate cuts could boost Genelux Corporation stockAnalyst Upgrades & AI Alerts You Can Actually Trust - Bollywood Helpline

Dec 23, 2025
pulisher
Dec 23, 2025

Flputnam Investment Management Co. Raises Holdings in Genelux Corporation $GNLX - MarketBeat

Dec 23, 2025
pulisher
Dec 20, 2025

Genelux (NASDAQ:GNLX) Cut to Sell at Wall Street Zen - Defense World

Dec 20, 2025
pulisher
Dec 13, 2025

Cappello, Genelux CTO, sells $14k in GNLX stock By Investing.com - Investing.com Nigeria

Dec 13, 2025
pulisher
Dec 12, 2025

Genelux (NASDAQ:GNLX) CEO Thomas Zindrick Sells 4,509 Shares - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Genelux (NASDAQ:GNLX) CEO Thomas Zindrick Sells 12,673 Shares of Stock - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Genelux SVP, Yu Yong, sells shares worth $16k By Investing.com - Investing.com Australia

Dec 12, 2025
pulisher
Dec 11, 2025

Genelux president sells $66k in GNLX stock By Investing.com - Investing.com Australia

Dec 11, 2025
pulisher
Dec 11, 2025

Genelux SVP, Yu Yong, sells shares worth $16k - Investing.com

Dec 11, 2025
pulisher
Dec 11, 2025

GENELUX Corp Executives Sell Shares to Cover Taxes - TradingView — Track All Markets

Dec 11, 2025
pulisher
Dec 11, 2025

VP Yu Surrenders 4,192 Of Genelux Corp [GNLX] - TradingView — Track All Markets

Dec 11, 2025
pulisher
Dec 11, 2025

Genelux reports Q3 EPS (21c), consensus (21c) - MSN

Dec 11, 2025
pulisher
Dec 09, 2025

Lake Street Sticks to Their Buy Rating for Genelux Corp. (GNLX) - The Globe and Mail

Dec 09, 2025
pulisher
Dec 06, 2025

Genelux price target raised to $20 from $10 at Maxim - MSN

Dec 06, 2025
pulisher
Dec 03, 2025

Genelux (NASDAQ:GNLX) Director Sells $50,000.00 in Stock - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

Genelux (GNLX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

GENELUX Corp Director Thomas John Sells 10,000 Shares - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

Dir Thomas Sells 10,000 ($50K) Of Genelux Corp [GNLX] - TradingView

Dec 02, 2025
pulisher
Dec 02, 2025

Wall Street analysts’ outlook for Genelux Corp (GNLX) - Setenews

Dec 02, 2025
pulisher
Nov 30, 2025

Global Retirement Partners LLC Acquires Shares of 228,676 Genelux Corporation $GNLX - MarketBeat

Nov 30, 2025
pulisher
Nov 27, 2025

MAI Capital Management Boosts Holdings in Genelux Corporation $GNLX - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

Genelux Corporation Executives to Participate in Fireside Chat at Piper Sandler 37th Annual Healthcare Conference - Quiver Quantitative

Nov 26, 2025
pulisher
Nov 26, 2025

Genelux (NASDAQ: GNLX) sets Dec. 3 fireside chat at Piper Sandler 37th Conference - Stock Titan

Nov 26, 2025
pulisher
Nov 23, 2025

Genelux Corp. Advances Phase 2 Study in NSCLC with Promising New Treatment - MSN

Nov 23, 2025
pulisher
Nov 20, 2025

What risks investors should watch in Genelux Corporation stockForecast Cut & Daily Technical Forecast Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Genelux Corporation's (NASDAQ:GNLX) 16% loss last week hit both individual investors who own 58% as well as institutions - simplywall.st

Nov 20, 2025
pulisher
Nov 20, 2025

Genelux initiated with a Buy at Titan Partners - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Combining machine learning predictions for Genelux Corporation2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What momentum indicators show for Genelux Corporation stockSwing Trade & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What valuation multiples suggest for Genelux Corporation stockWall Street Watch & Accurate Entry/Exit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Genelux Corporation stock benefit from AI adoptionWeekly Trade Recap & High Return Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Can Genelux Corporation stock double in next 5 years2025 Short Interest & Reliable Price Action Trade Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Is Genelux Corporation stock attractive after correctionWatch List & Safe Entry Point Identification - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

How hedge fund analytics apply to Genelux Corporation stock2025 Price Targets & Smart Swing Trading Techniques - newser.com

Nov 16, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
Kapitalisierung:     |  Volumen (24h):